Collins Helen Louise
CHIEF MEDICAL OFFICER
CIK: 1701247
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| May 18, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 223 | $41.21 | $9,188.76 | View Details Filing |
| May 18, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 1,302 | $40.25 | $52,401.98 | View Details Filing |
| May 18, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 3,475 | $39.53 | $137,380.65 | View Details Filing |
| Apr 17, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 140 | $45.81 | $6,413.50 | View Details Filing |
| Apr 17, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 2,441 | $48.06 | $117,303.48 | View Details Filing |
| Apr 17, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 2,419 | $47.39 | $114,635.44 | View Details Filing |
| Mar 25, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 40,000 | $35.10 | $1,404,024.00 | View Details Filing |
| Mar 17, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 5,000 | $27.76 | $138,800.00 | View Details Filing |
| Mar 10, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 10,129 | $30.19 | $305,826.92 | View Details Filing |
| Mar 9, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 29,871 | $30.02 | $896,811.06 | View Details Filing |